Sone Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-40,158
Closed -$19.7M 127
2026
Q1
$19.7M Buy
40,158
+29,314
+270% +$15.9M 1.66% 20
2025
Q4
$6.28M Buy
10,844
+4,053
+60% +$2.29M 0.51% 69
2025
Q3
$3.29M Sell
6,791
-43,523
-87% -$20.3M 0.28% 85
2025
Q2
$20.4M Buy
50,314
+19,904
+65% +$8.32M 1.88% 14
2025
Q1
$15.1M Buy
30,410
+12,214
+67% +$6.62M 1.56% 21
2024
Q4
$9.47M Buy
+18,196
New +$10M 1.2% 31

Other funds holding TMO

Sone Capital Management's TMO Position: Q2 2026 in Review

Sone Capital Management sold out of Thermo Fisher Scientific (TMO) in Q2 2026, closing a stake of 40,158 shares — an estimated $19.7M sold.

Sone Capital Management first reported a position in TMO in Q4 2024 and held it in 6 quarters. The position peaked at $20.4M in Q2 2025. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Sone Capital Management reported no remaining Thermo Fisher Scientific position as of Q2 2026 after selling out during the quarter.
  • Sone Capital Management sold 40,158 Thermo Fisher Scientific shares in Q2 2026, an estimated $19.7M.
  • Sone Capital Management first reported a position in Thermo Fisher Scientific in Q4 2024 and held it in 6 quarters.
  • Sone Capital Management's Thermo Fisher Scientific position peaked at $20.4M in Q2 2025.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Sone Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.